TROMBETTA, CLAUDIA MARIA
 Distribuzione geografica
Continente #
EU - Europa 7.433
NA - Nord America 6.683
AS - Asia 4.094
SA - Sud America 845
AF - Africa 202
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.267
Nazione #
US - Stati Uniti d'America 6.521
GB - Regno Unito 2.943
RU - Federazione Russa 1.384
SG - Singapore 1.294
CN - Cina 1.156
IT - Italia 1.052
BR - Brasile 699
IE - Irlanda 678
VN - Vietnam 558
HK - Hong Kong 345
FR - Francia 275
SE - Svezia 262
DE - Germania 234
KR - Corea 208
UA - Ucraina 180
FI - Finlandia 167
IN - India 136
BD - Bangladesh 111
CA - Canada 79
ZA - Sudafrica 75
AR - Argentina 61
MX - Messico 46
NL - Olanda 45
TR - Turchia 44
IQ - Iraq 40
PL - Polonia 39
AT - Austria 38
CI - Costa d'Avorio 37
ES - Italia 32
JP - Giappone 27
ID - Indonesia 25
BE - Belgio 22
MA - Marocco 21
EC - Ecuador 20
CO - Colombia 19
NG - Nigeria 19
KE - Kenya 18
PK - Pakistan 18
CZ - Repubblica Ceca 15
LT - Lituania 14
PH - Filippine 13
VE - Venezuela 12
JM - Giamaica 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
SA - Arabia Saudita 10
JO - Giordania 9
PE - Perù 9
AZ - Azerbaigian 8
EG - Egitto 8
PY - Paraguay 8
AL - Albania 7
CR - Costa Rica 7
IR - Iran 7
MY - Malesia 7
OM - Oman 7
IL - Israele 6
LB - Libano 6
NP - Nepal 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
HU - Ungheria 5
RO - Romania 5
TN - Tunisia 5
DK - Danimarca 4
ET - Etiopia 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
MD - Moldavia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
Totale 19.248
Città #
Southend 2.802
Dallas 1.225
Dublin 669
Singapore 653
Ashburn 459
Fairfield 452
Santa Clara 435
Moscow 375
Chandler 354
Hong Kong 325
Hefei 303
Siena 279
Beijing 260
San Jose 248
Woodbridge 236
Seoul 208
Seattle 204
Council Bluffs 202
Houston 196
Wilmington 164
Ho Chi Minh City 162
Ann Arbor 155
Los Angeles 145
Jacksonville 141
Cambridge 131
Dong Ket 113
Hanoi 110
The Dalles 98
Lauterbourg 94
Princeton 87
Helsinki 84
New York 83
Milan 81
Munich 80
Johannesburg 65
Rome 65
Florence 57
Lappeenranta 56
Buffalo 53
São Paulo 52
San Diego 49
Bengaluru 47
Orem 43
Nanjing 42
Shanghai 41
Boardman 40
San Mateo 39
Abidjan 37
Chicago 37
Redondo Beach 33
Warsaw 33
Nuremberg 32
Frankfurt am Main 30
Montreal 29
London 26
Dearborn 24
Baghdad 23
Phoenix 23
Tokyo 23
Toronto 23
Denver 22
Brooklyn 21
Rio de Janeiro 21
Stockholm 21
Vienna 21
Brussels 20
Da Nang 20
Livorno 20
Chennai 19
Guangzhou 18
Haiphong 18
Abuja 17
Bari 17
Málaga 17
Nanchang 17
Shenyang 17
Belo Horizonte 16
Brasília 15
Columbus 15
Manchester 15
San Francisco 15
Portsmouth 14
Tianjin 14
Amsterdam 13
Brescia 13
Mexico City 13
Redwood City 13
Dhaka 12
Hải Dương 12
Kunming 12
Mumbai 12
Piscataway 12
Porto Alegre 12
Turku 12
Washington 12
Atlanta 11
Fremont 11
Izmir 11
Arezzo 10
Changsha 10
Totale 13.246
Nome #
"OKKIO alla salute 2014" results from the Tuscan sample 684
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 623
The virucidal potential effects of violet-blue light on influenza D virus 555
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 545
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 480
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 457
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 424
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 344
Egg-Independent Influenza Vaccines and Vaccine Candidates 329
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 295
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 292
Challenges in the development of egg-independent vaccines for influenza 271
Emerging influenza strains in the last two decades: A threat of a new pandemic? 260
Influenza immunology evaluation and correlates of protection: a focus on vaccines 257
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 254
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 252
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 242
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 237
Solubilization methods and reference 2-DE map of cow milk fat globules 233
Impact of erythrocyte species on assays for influenza serology 228
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 219
Measles in pregnancy: a threat for Italian women? 206
Influenza vaccines: Evaluation of the safety profile 201
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 198
Elettroforesi bidimensionale 198
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 193
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 193
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 192
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 190
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 189
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 186
In Vitro Antiviral and Virucidal Activity of Ozone against Feline Calicivirus 185
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 183
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 182
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 173
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 172
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 171
Water and air ozone treatment as an alternative sanitizing technology 171
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 170
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 170
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 170
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 169
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 168
Immunoproteomics of myasthenia 168
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 166
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 163
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 163
Evaluating influenza vaccines: Progress and perspectives 162
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy 162
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 156
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 154
Is influenza A/H10N8 a potential candidate for the next pandemic? 153
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region 152
Trend della prevalenza di sovrappeso e obesità nei bambini toscani in età scolare dal 2002 al 2016 [Trends of overweight and obesity prevalence among schoolchildren in Tuscany Region (Central Italy), period 2002-2016] 152
There is a correlation between nutritional status, Self-Rated Health and Life Satisfaction? Evidence from 2018 Health Behaviour in School-aged Children cross sectional study in a sample of Italian adolescents living in Tuscany Region 149
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 148
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 147
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 145
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 140
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 139
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 138
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 138
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 137
Low prevalence of antibodies against pertussis in pregnant women in Italy 136
null 136
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 133
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 128
Tecnologie per l'analisi del proteoma 128
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 126
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 126
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 126
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 126
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 125
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 125
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 124
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines 122
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 120
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 118
null 116
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study 115
Seroprevalence of hepatitis e virus in forestry workers from trentino-alto adige region (Northern Italy) 114
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 114
Assessment of Pertussis Underreporting in Italy 113
Sorveglianza virologica della nuova variante del virus influenzale A/H1N1 nell’Area Vasta Toscana sud 112
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 111
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 110
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 110
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 108
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 107
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 106
Measles Susceptibility in Apulia: The Italian Mirror? 106
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 105
Assessing the virucidal activity of essential oils against feline calicivirus, a non-enveloped virus used as surrogate of norovirus 103
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 103
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 100
Virucidal activity in vitro of mouthwashes against a feline coronavirus type II 98
Virucidal Activity of Lemon Essential Oil against Feline Calicivirus Used as Surrogate for Norovirus 97
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy 92
In vitro virucidal activity of mouthwashes on SARS-CoV-2 92
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy) 89
Totale 18.763
Categoria #
all - tutte 58.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021244 0 0 0 0 0 0 0 0 0 0 0 244
2021/20221.116 135 177 143 98 49 35 52 37 61 78 95 156
2022/20231.154 67 144 137 144 100 207 44 101 123 32 33 22
2023/20241.134 36 42 90 45 42 251 437 21 13 53 15 89
2024/20253.228 62 227 301 218 366 223 106 162 317 127 315 804
2025/20268.054 620 916 1.261 1.035 1.363 320 825 255 371 497 363 228
Totale 19.681